In addition, many novel liver disease biomarkers were discovered, such as EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), SAA2, CPN2, ANPEP, TGFBI, and FGG (supplemental Fig. S15B). This evidence concerns the gene ANPEP and liver disorder.